ZUMA-3: A phase 1/2 multi-center study evaluation the safety and efficacy of KTE-C19 anti-CD19 CAR T cells in adult patients with relapsed/refractory B precursor acute lymphoblastic leukemia (R/R ALL)
Shah, B., Castro, J., Gökbuget, N., Kersten, M. José, Hagenbeek, T., Wierda, W., Schiller, G., Bot, A., Rossi, J.M., Jiang, Y., Navale, L., Stout, S., Aycock, J., Wiezorek, J., Jain, R.Volume:
27
Language:
english
Journal:
Annals of Oncology
DOI:
10.1093/annonc/mdw368.58
Date:
October, 2016
File:
PDF, 41 KB
english, 2016
File converter
More search results
More benefits 
